Xanadu Quantum (XNDU) Stock Drops 4% as Losses Widen Despite Revenue Beat

TLDR

• Xanadu posted Q1 2026 revenue of $2.8 million, a fourfold increase from $700,000 a year ago, beating analyst estimates of $1.1 million.
• Net losses widened to $20.6 million (28 cents a share), up from $12.2 million (22 cents a share) in the prior year.
• The stock dropped 4.3% in Friday premarket to $14.48, well below its all-time closing high of $36.12 on May 1.
• Cash on hand surged to $272.5 million, up from $16.2 million, thanks to proceeds from its SPAC merger including a $275 million private investment.
• Canaccord Genuity reiterated a Buy rating with a $45 price target, calling recent weakness an “opportunistic” entry point.

Xanadu Quantum Technologies (XNDU) went public on March 27 through a merger with Crane Harbor Acquisition Corp. and has already put up its first earnings report as a listed company. The numbers were a mixed bag, and the market made its feelings clear early Friday.

$XNDU | Quantum Photonics Hitting Hyper-Growth in Q1

Actual Revenue: $3.42M (+388% YoY). Cloud access is soaring as enterprise enters the quantum arena.
R&D Surge: Net loss at $22.4M. Xanadu is spending big to build the world's first fault-tolerant photonic… pic.twitter.com/Nnm0VjQonD

— AryaFin (@AryaFintech) May 14, 2026

The stock fell 4.3% in premarket to $14.48, having closed Thursday at $14.74.

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares, XNDU

Revenue came in at $2.8 million for Q1 2026, a 300% jump from $700,000 in the same period last year. That easily topped the $1.1 million Wall Street had been expecting. Growth was driven mainly by DARPA projects and government grants.

The flip side: losses are growing too. Net loss widened to $20.6 million, or 28 cents a share, compared to $12.2 million, or 22 cents a share, a year ago. On an adjusted EBITDA basis, the company lost $13.9 million versus $10.6 million previously.

Heavy research spending and rising administrative costs were the main drivers of the wider losses. That’s not unusual for a company at this stage — Xanadu is still focused on building out its technology rather than commercializing it at scale.

One bright spot: cash. Xanadu ended March with $272.5 million in cash and equivalents, up from just $16.2 million a year ago. The jump came from its SPAC merger proceeds, which included a $275 million private investment.

PennyLane Continues to Build Momentum

Xanadu’s open-source PennyLane platform, used for quantum machine learning, hit over 35,000 active users and averaged 200,000 monthly downloads as of early March. That user base is a key part of the company’s longer-term commercial story.

The company also maintains active relationships with AMD and Lockheed Martin, two partnerships that analysts have pointed to as a sign of growing industry credibility.

Stock Has Had a Wild Ride Since Listing

XNDU debuted at $11.50 on March 27, surged as high as $42.44 on April 16, and hit its highest close of $36.12 on May 1. It has pulled back hard since then.

A big reason for the drop: on May 4, Xanadu registered nearly 294 million shares held by early investors, founders, and private backers for potential public sale. The flood of potential supply spooked the market.

Canaccord Genuity reiterated its Buy rating and $45 price target on Friday. Analyst Kingsley Crane said Xanadu’s photonics-based approach gives it unique scaling advantages over other quantum computing methods, with scaling tied more to wafer production cycles than scientific breakthroughs.

The stock is currently trading around $15.13, down roughly 64% from its April high.

The post Xanadu Quantum (XNDU) Stock Drops 4% as Losses Widen Despite Revenue Beat appeared first on CoinCentral.